nodes	percent_of_prediction	percent_of_DWPC	metapath
Almotriptan—MAOA—locus ceruleus—narcolepsy	0.19	0.339	CbGeAlD
Almotriptan—HTR1B—brainstem—narcolepsy	0.033	0.0589	CbGeAlD
Almotriptan—HTR1D—brainstem—narcolepsy	0.0319	0.057	CbGeAlD
Almotriptan—HTR1B—forebrain—narcolepsy	0.0318	0.0569	CbGeAlD
Almotriptan—HTR1D—forebrain—narcolepsy	0.0308	0.0551	CbGeAlD
Almotriptan—MAOA—brainstem—narcolepsy	0.0243	0.0434	CbGeAlD
Almotriptan—MAOA—forebrain—narcolepsy	0.0235	0.0419	CbGeAlD
Almotriptan—FMO3—brain—narcolepsy	0.0225	0.0402	CbGeAlD
Almotriptan—HTR1D—Serotonin receptors—HTR2A—narcolepsy	0.021	0.0478	CbGpPWpGaD
Almotriptan—HTR1B—midbrain—narcolepsy	0.021	0.0376	CbGeAlD
Almotriptan—HTR1B—Serotonin receptors—HTR2A—narcolepsy	0.0206	0.0468	CbGpPWpGaD
Almotriptan—HTR1D—midbrain—narcolepsy	0.0204	0.0364	CbGeAlD
Almotriptan—MAOA—medulla oblongata—narcolepsy	0.017	0.0303	CbGeAlD
Almotriptan—HTR1D—Amine ligand-binding receptors—HRH3—narcolepsy	0.0158	0.0359	CbGpPWpGaD
Almotriptan—MAOA—midbrain—narcolepsy	0.0155	0.0277	CbGeAlD
Almotriptan—HTR1B—Amine ligand-binding receptors—HRH3—narcolepsy	0.0155	0.0351	CbGpPWpGaD
Almotriptan—CYP2D6—brainstem—narcolepsy	0.0145	0.0258	CbGeAlD
Almotriptan—CYP2D6—forebrain—narcolepsy	0.0139	0.0249	CbGeAlD
Almotriptan—HTR1B—brain—narcolepsy	0.0132	0.0236	CbGeAlD
Almotriptan—HTR1D—brain—narcolepsy	0.0128	0.0228	CbGeAlD
Almotriptan—CYP2E1—medulla oblongata—narcolepsy	0.0127	0.0227	CbGeAlD
Almotriptan—MAOA—brain—narcolepsy	0.00974	0.0174	CbGeAlD
Almotriptan—HTR1D—Monoamine GPCRs—HTR2A—narcolepsy	0.00936	0.0213	CbGpPWpGaD
Almotriptan—HTR1B—Monoamine GPCRs—HTR2A—narcolepsy	0.00916	0.0208	CbGpPWpGaD
Almotriptan—CYP2C8—brain—narcolepsy	0.00868	0.0155	CbGeAlD
Almotriptan—FMO3—SIDS Susceptibility Pathways—TAC1—narcolepsy	0.00824	0.0187	CbGpPWpGaD
Almotriptan—HTR1D—Amine ligand-binding receptors—HTR2A—narcolepsy	0.00787	0.0179	CbGpPWpGaD
Almotriptan—HTR1B—Amine ligand-binding receptors—HTR2A—narcolepsy	0.0077	0.0175	CbGpPWpGaD
Almotriptan—CYP2E1—brain—narcolepsy	0.00731	0.0131	CbGeAlD
Almotriptan—HTR1D—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.00664	0.0151	CbGpPWpGaD
Almotriptan—HTR1D—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.00664	0.0151	CbGpPWpGaD
Almotriptan—HTR1B—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.0065	0.0148	CbGpPWpGaD
Almotriptan—HTR1B—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.0065	0.0148	CbGpPWpGaD
Almotriptan—HTR1D—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.00641	0.0146	CbGpPWpGaD
Almotriptan—HTR1B—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.00628	0.0143	CbGpPWpGaD
Almotriptan—CYP2D6—brain—narcolepsy	0.00579	0.0103	CbGeAlD
Almotriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.00569	0.0129	CbGpPWpGaD
Almotriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.00569	0.0129	CbGpPWpGaD
Almotriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.00557	0.0127	CbGpPWpGaD
Almotriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.00557	0.0127	CbGpPWpGaD
Almotriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.00549	0.0125	CbGpPWpGaD
Almotriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.00538	0.0122	CbGpPWpGaD
Almotriptan—HTR1D—G alpha (i) signalling events—PENK—narcolepsy	0.00524	0.0119	CbGpPWpGaD
Almotriptan—HTR1B—G alpha (i) signalling events—PENK—narcolepsy	0.00513	0.0116	CbGpPWpGaD
Almotriptan—FMO3—SIDS Susceptibility Pathways—HTR2A—narcolepsy	0.00496	0.0113	CbGpPWpGaD
Almotriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.00467	0.0106	CbGpPWpGaD
Almotriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.00457	0.0104	CbGpPWpGaD
Almotriptan—HTR1D—GPCR ligand binding—HCRTR1—narcolepsy	0.00433	0.00984	CbGpPWpGaD
Almotriptan—HTR1D—GPCR ligand binding—HCRTR2—narcolepsy	0.00433	0.00984	CbGpPWpGaD
Almotriptan—HTR1B—GPCR ligand binding—HCRTR2—narcolepsy	0.00424	0.00964	CbGpPWpGaD
Almotriptan—HTR1B—GPCR ligand binding—HCRTR1—narcolepsy	0.00424	0.00964	CbGpPWpGaD
Almotriptan—HTR1D—GPCR ligand binding—P2RY11—narcolepsy	0.00418	0.0095	CbGpPWpGaD
Almotriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00416	0.00946	CbGpPWpGaD
Almotriptan—HTR1B—GPCR ligand binding—P2RY11—narcolepsy	0.0041	0.00931	CbGpPWpGaD
Almotriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00408	0.00926	CbGpPWpGaD
Almotriptan—MAOA—SIDS Susceptibility Pathways—TAC1—narcolepsy	0.00394	0.00895	CbGpPWpGaD
Almotriptan—HTR1D—G alpha (i) signalling events—HRH3—narcolepsy	0.0039	0.00887	CbGpPWpGaD
Almotriptan—HTR1B—G alpha (i) signalling events—HRH3—narcolepsy	0.00382	0.00869	CbGpPWpGaD
Almotriptan—HTR1D—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00362	0.00823	CbGpPWpGaD
Almotriptan—HTR1D—GPCR ligand binding—HCRT—narcolepsy	0.00356	0.00808	CbGpPWpGaD
Almotriptan—HTR1B—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00355	0.00806	CbGpPWpGaD
Almotriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00354	0.00804	CbGpPWpGaD
Almotriptan—HTR1B—GPCR ligand binding—HCRT—narcolepsy	0.00348	0.00791	CbGpPWpGaD
Almotriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00347	0.00788	CbGpPWpGaD
Almotriptan—FMO3—Metabolism—CHKB—narcolepsy	0.00328	0.00744	CbGpPWpGaD
Almotriptan—HTR1D—GPCR ligand binding—PENK—narcolepsy	0.00317	0.0072	CbGpPWpGaD
Almotriptan—HTR1B—GPCR ligand binding—PENK—narcolepsy	0.0031	0.00705	CbGpPWpGaD
Almotriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.0031	0.00705	CbGpPWpGaD
Almotriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00304	0.00691	CbGpPWpGaD
Almotriptan—HTR1D—GPCR ligand binding—TRH—narcolepsy	0.0027	0.00612	CbGpPWpGaD
Almotriptan—HTR1B—GPCR ligand binding—TRH—narcolepsy	0.00264	0.006	CbGpPWpGaD
Almotriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00257	0.00584	CbGpPWpGaD
Almotriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00257	0.00584	CbGpPWpGaD
Almotriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00252	0.00572	CbGpPWpGaD
Almotriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00252	0.00572	CbGpPWpGaD
Almotriptan—HTR1D—GPCR downstream signaling—HCRTR2—narcolepsy	0.00245	0.00556	CbGpPWpGaD
Almotriptan—HTR1D—GPCR downstream signaling—HCRTR1—narcolepsy	0.00245	0.00556	CbGpPWpGaD
Almotriptan—HTR1B—GPCR downstream signaling—HCRTR2—narcolepsy	0.0024	0.00545	CbGpPWpGaD
Almotriptan—HTR1B—GPCR downstream signaling—HCRTR1—narcolepsy	0.0024	0.00545	CbGpPWpGaD
Almotriptan—MAOA—SIDS Susceptibility Pathways—HTR2A—narcolepsy	0.00237	0.00538	CbGpPWpGaD
Almotriptan—HTR1D—GPCR downstream signaling—P2RY11—narcolepsy	0.00236	0.00537	CbGpPWpGaD
Almotriptan—HTR1D—GPCR ligand binding—HRH3—narcolepsy	0.00236	0.00537	CbGpPWpGaD
Almotriptan—HTR1B—GPCR downstream signaling—P2RY11—narcolepsy	0.00232	0.00526	CbGpPWpGaD
Almotriptan—HTR1B—GPCR ligand binding—HRH3—narcolepsy	0.00231	0.00526	CbGpPWpGaD
Almotriptan—FMO3—Metabolism—CPT1B—narcolepsy	0.00223	0.00506	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—HCRTR2—narcolepsy	0.00222	0.00505	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—HCRTR1—narcolepsy	0.00222	0.00505	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—HCRTR2—narcolepsy	0.00218	0.00495	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—HCRTR1—narcolepsy	0.00218	0.00495	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—P2RY11—narcolepsy	0.00215	0.00488	CbGpPWpGaD
Almotriptan—FMO3—SIDS Susceptibility Pathways—TNF—narcolepsy	0.00213	0.00485	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—P2RY11—narcolepsy	0.0021	0.00478	CbGpPWpGaD
Almotriptan—HTR1D—GPCR downstream signaling—HCRT—narcolepsy	0.00201	0.00457	CbGpPWpGaD
Almotriptan—HTR1B—GPCR downstream signaling—HCRT—narcolepsy	0.00197	0.00447	CbGpPWpGaD
Almotriptan—HTR1D—GPCR ligand binding—TAC1—narcolepsy	0.00196	0.00445	CbGpPWpGaD
Almotriptan—HTR1D—GPCR ligand binding—NPS—narcolepsy	0.00196	0.00445	CbGpPWpGaD
Almotriptan—HTR1B—GPCR ligand binding—NPS—narcolepsy	0.00192	0.00436	CbGpPWpGaD
Almotriptan—HTR1B—GPCR ligand binding—TAC1—narcolepsy	0.00192	0.00436	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.00186	0.00423	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—HCRT—narcolepsy	0.00183	0.00415	CbGpPWpGaD
Almotriptan—HTR1D—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00181	0.0041	CbGpPWpGaD
Almotriptan—HTR1D—GPCR downstream signaling—PENK—narcolepsy	0.00179	0.00407	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—HCRT—narcolepsy	0.00179	0.00406	CbGpPWpGaD
Almotriptan—HTR1B—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00177	0.00402	CbGpPWpGaD
Almotriptan—HTR1B—GPCR downstream signaling—PENK—narcolepsy	0.00175	0.00399	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.00166	0.00378	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—PENK—narcolepsy	0.00163	0.0037	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—PENK—narcolepsy	0.00159	0.00362	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—CHKB—narcolepsy	0.00157	0.00356	CbGpPWpGaD
Almotriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00155	0.00352	CbGpPWpGaD
Almotriptan—HTR1D—GPCR downstream signaling—TRH—narcolepsy	0.00152	0.00346	CbGpPWpGaD
Almotriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00152	0.00344	CbGpPWpGaD
Almotriptan—HTR1B—GPCR downstream signaling—TRH—narcolepsy	0.00149	0.00339	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—TRH—narcolepsy	0.00138	0.00314	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—TRH—narcolepsy	0.00135	0.00308	CbGpPWpGaD
Almotriptan—HTR1D—GPCR downstream signaling—HRH3—narcolepsy	0.00134	0.00303	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—HCRTR1—narcolepsy	0.00131	0.00298	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—HCRTR2—narcolepsy	0.00131	0.00298	CbGpPWpGaD
Almotriptan—HTR1B—GPCR downstream signaling—HRH3—narcolepsy	0.00131	0.00297	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.0013	0.00294	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—HCRTR2—narcolepsy	0.00129	0.00292	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—HCRTR1—narcolepsy	0.00129	0.00292	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—P2RY11—narcolepsy	0.00127	0.00288	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.00127	0.00288	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—P2RY11—narcolepsy	0.00124	0.00282	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—HRH3—narcolepsy	0.00121	0.00276	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—HRH3—narcolepsy	0.00119	0.0027	CbGpPWpGaD
Almotriptan—HTR1D—GPCR ligand binding—HTR2A—narcolepsy	0.00118	0.00268	CbGpPWpGaD
Almotriptan—HTR1B—GPCR ligand binding—HTR2A—narcolepsy	0.00115	0.00262	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.00113	0.00257	CbGpPWpGaD
Almotriptan—HTR1D—GPCR downstream signaling—NPS—narcolepsy	0.00111	0.00251	CbGpPWpGaD
Almotriptan—HTR1D—GPCR downstream signaling—TAC1—narcolepsy	0.00111	0.00251	CbGpPWpGaD
Almotriptan—HTR1B—GPCR downstream signaling—TAC1—narcolepsy	0.00108	0.00246	CbGpPWpGaD
Almotriptan—HTR1B—GPCR downstream signaling—NPS—narcolepsy	0.00108	0.00246	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—HCRT—narcolepsy	0.00108	0.00245	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—CPT1B—narcolepsy	0.00106	0.00242	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—HCRT—narcolepsy	0.00106	0.0024	CbGpPWpGaD
Almotriptan—MAOA—SIDS Susceptibility Pathways—TNF—narcolepsy	0.00102	0.00232	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—TAC1—narcolepsy	0.00101	0.00228	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—NPS—narcolepsy	0.00101	0.00228	CbGpPWpGaD
Almotriptan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—narcolepsy	0.000999	0.00227	CbGpPWpGaD
Almotriptan—CYP1A2—Aryl Hydrocarbon Receptor—TNF—narcolepsy	0.000999	0.00227	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—TAC1—narcolepsy	0.000984	0.00224	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—NPS—narcolepsy	0.000984	0.00224	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—PENK—narcolepsy	0.000961	0.00218	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—CHKB—narcolepsy	0.00096	0.00218	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—PENK—narcolepsy	0.000941	0.00214	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.000881	0.002	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—CHKB—narcolepsy	0.00083	0.00189	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—TRH—narcolepsy	0.000817	0.00186	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—TRH—narcolepsy	0.0008	0.00182	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—CHKB—narcolepsy	0.000741	0.00168	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—HRH3—narcolepsy	0.000717	0.00163	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—HRH3—narcolepsy	0.000702	0.00159	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—CHKB—narcolepsy	0.000681	0.00155	CbGpPWpGaD
Almotriptan—HTR1D—GPCR downstream signaling—HTR2A—narcolepsy	0.000666	0.00151	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—CPT1B—narcolepsy	0.000653	0.00148	CbGpPWpGaD
Almotriptan—HTR1B—GPCR downstream signaling—HTR2A—narcolepsy	0.000652	0.00148	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—HTR2A—narcolepsy	0.000605	0.00137	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—NPS—narcolepsy	0.000594	0.00135	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—TAC1—narcolepsy	0.000594	0.00135	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—HTR2A—narcolepsy	0.000592	0.00135	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—TAC1—narcolepsy	0.000581	0.00132	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—NPS—narcolepsy	0.000581	0.00132	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—CHKB—narcolepsy	0.000577	0.00131	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—CPT1B—narcolepsy	0.000564	0.00128	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—CPT1B—narcolepsy	0.000504	0.00114	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—CPT1B—narcolepsy	0.000463	0.00105	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—CHKB—narcolepsy	0.000446	0.00101	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—CPT1B—narcolepsy	0.000392	0.000892	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—HTR2A—narcolepsy	0.000357	0.000812	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—HTR2A—narcolepsy	0.00035	0.000795	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—CPT1B—narcolepsy	0.000303	0.000688	CbGpPWpGaD
